A Study to Test the Repeatability and Reproducibility in Rod Intercept Time Within the AdaptDx Pro in Healthy Subjects With Normal Vision (FlashForward)
NCT07860905
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
The purpose of this study is to test the repeatability and reproducibility in Rod Intercept (RI) time with two AdaptDx Pro devices in healthy subjects with normal vision.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- No Disease
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 22 to 49 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- AdaptDx, Inc.
- Last updated on ClinicalTrials.gov
- October 6, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Washington · 1
- Pacific NorthWest Retina (Silverdale) · Silverdale, WA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.